Novo Nordisk A/S Operating Cycle 2011-2026 | NVO

Annual Operating Cycle Novo Nordisk A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	426	395	384	361	357	313	322	343

All numbers in DKK currency

Maximum	Minimum	Average
426	313	363

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Alnylam Pharmaceuticals ALNY	102	$ 320.13	-3.98 %	$ 41.9 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Amphastar Pharmaceuticals AMPH	237	$ 21.81	0.6 %	$ 1.02 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Akebia Therapeutics AKBA	210	$ 1.35	-12.9 %	$ 347 M	USA
Aquestive Therapeutics AQST	223	$ 4.26	0.47 %	$ 456 M	USA
Arcutis Biotherapeutics ARQT	291	$ 24.19	-1.59 %	$ 3.08 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	129	$ 1.61	8.05 %	$ 428 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Clearside Biomedical CLSD	61.7	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	321	$ 33.86	-0.03 %	$ 2.25 B	USA
bluebird bio BLUE	127	-	-	$ 546 M	USA